Clinical trial Recruiting at 1 site Observational Ages 18 and up

Observing patients with tuberculosis and related infections

Official title: Epidemiological, Demographic and Clinical Aspects of Patients With Tuberculosis, Mycobacteriosis or Infection Latent Tuberculosis

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06764576 · Data updated 2026-11-12

This study looks at patients suspected of having tuberculosis or related infections to see how these conditions affect them and how well different tests work to diagnose them.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment13000 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedDecember 19, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 8, 2025
Trial IDNCT06764576 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 years or older with a clinical or radiological suspicion of TB, non-tubercular mycobacteriosis, or latent tuberculosis infection.

Probably not a fit

Patients without any clinical or radiological suspicion of TB or related infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with clinical or radiological suspicion of tuberculosis (TB), non-tubercular mycobacteriosis, or latent tuberculosis infection (ITBL). It involves a retrospective analysis of data from January 2012 to May 2021, as well as a prospective analysis from June 2021 to December 2026. The study aims to assess the epidemiological, demographic, and clinical aspects of these patients, evaluate the diagnostic accuracy of various methods for TB and mycobacterial infections, and analyze the microbiological characteristics of the strains involved. The outcomes will help improve understanding and management of TB and related infections.

Why it matters

Potential benefit: If successful, this study could enhance the diagnosis and treatment of tuberculosis and related infections, ultimately improving patient outcomes.

How similar studies have gone: Other studies have shown success in identifying and managing tuberculosis and mycobacterial infections, making this approach relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age of 18 years or more,
* clinical/radiological suspicion of TB or non-tubercular mycobacteriosis or ITBL for which sent to the Microbiology laboratory at least one biological sample for the mycobacteria and/or a blood sample for the IGRA test;
* Obtaining informed consent.

Exclusion Criteria:

* None

Where it's running

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Paola Dal Monte, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Paola Dal Monte, MD
  • Email: paola.dalmonte@unibo.it
  • Phone: 0390512145293

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.